651 filings
Page 7 of 33
8-K
9e3h4o ck
19 Nov 20
Regulation FD Disclosure
11:34am
8-K
o352h r58cbf8onn
12 Nov 20
Vaxart Reports Third Quarter 2020 Financial Results and Provides Business Update
4:03pm
8-K
etylrs95iv u47xmn
14 Oct 20
Entry into a Material Definitive Agreement
6:04am
424B5
ufl8bi9789623 d5bjh0
13 Oct 20
Prospectus supplement for primary offering
5:27pm
8-K
3mp0 g0lrltu89
8 Oct 20
Entry into a Material Definitive Agreement
3:40pm
8-K
08l7xxjz4vjk
23 Sep 20
Regulation FD Disclosure
1:15pm
8-K
jvox6xr80 2t
15 Sep 20
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
12:00am
8-K
p8udi6bu f2z1t56w
27 Aug 20
Vaxart Appoints Karen J. Wilson to its Board of Directors
8:09am
8-K
tvc8bbguc
6 Aug 20
Vaxart Announces Second Quarter 2020 Results
4:07pm
8-K
6554c0g7
13 Jul 20
Other Events
4:13pm
8-K
293zuwq
8 Jul 20
Results of Operations and Financial Condition
8:51am
S-3ASR
ohtq5a2eq u4616
8 Jul 20
Automatic shelf registration
8:50am
S-8
fmx9re
7 Jul 20
Registration of securities for employees
4:20pm
8-K
z2z4f3 htedv0e3pfyoj
30 Jun 20
Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP
5:24pm
8-K
iqgl8nospvcczipkwu
23 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:24pm
8-K
036ic0
18 Jun 20
Regulation FD Disclosure
1:26pm
8-K
kpswjq1 b8epr9
15 Jun 20
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
5:25pm
8-K
ge0areab92f1lvfz xtc
9 Jun 20
Departure of Directors or Certain Officers
4:26pm